Active Biotech AB (OSTO:ACTI) Short Interest


OSTO:ACTI Active Biotech AB OSTO:ACTI
28 GF Score
Price kr5.75
! 1 Warning Sign
View Full Analysis

What is Active Biotech AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

OSTO:ACTI vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Active Biotech AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Active Biotech AB Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Active Biotech AB's Short Interest distribution charts can be found below:

* The bar in red indicates where Active Biotech AB's Short Interest falls into.


OSTO:ACTI
28GF Score
Active Biotech AB OSTO:ACTI
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Active Biotech AB Business Description

Other Exchanges 0GQU:UKBTP:Germany
Address Scheelevagen 22, P.O. Box 724, Lund, SWE, 223 63
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy. Its project portfolio includes both small orally active immunomodulatory molecules and antibody-based immunotherapy. Its pipeline products are: Tasquinimod, Laquinimod, and Naptumomab.
28GF Score

Get the complete analysis for OSTO:ACTI

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr5.75
Price